20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9192 | BIIB068 | BTK | |
BIIB068 is an selective, reversible and orally active BTK inhibitor (IC50 = 1 nM, Kd = 0.3 nM). BIIB068 is 400 times more selective for BTK than other kinases. | |||
T9054 | RO6889678 | HBV | |
RO6889678 is HBV inhibitor with a complex ADME profile. | |||
TQ0008 | MT-DADMe-ImmA | Methylthio-DADMe-Immucillin A,MTDIA | Others |
MT-DADMe-ImmA (MTDIA) is an inhibitor of human 5'-methylthioadenosine phosphorylase (MTAP, Ki: 90 pM). | |||
T9643 | ZN-c3 | Wee1 | |
ZN-c3 is a potent and selective Wee1 inhibitor with balanced potency, ADME, and pharmacokinetic properties. | |||
T2249 | XEN445 | XEN 445,XEN-445 | Lipase |
XEN445, a potent and selective endothelial lipase(EL) inhibitor (IC50=0.237 uM), exhibitis good ADME and PK properties. | |||
T4347 | ML355 | Lipoxygenase | |
ML355, a specific, effective 12-Lipoxygenase(12-LOX) inhibitors(IC50=0.34 μM), possess favorable ADME properties. | |||
T24480 | MK-8325 | MK 8325,MK8325 | HCV Protease |
MK-8325 is a potent and orally available HCV NS5A inhibitor with replicative activity against a wide range of genotypes.MK-8325 has demonstrated bioavailability in in vitro and in vivo assays and has a favorable overall ... | |||
T31982 | GNE-9822 | GNE 9822 | |
GNE-9822 is a potent selective ITK inhibitor that shows favorable ADME properties in preclinical species. | |||
T24101 | GR-125487 | GR125487,GR 125487 | |
GR-125487 is a 5-HT4R partial agonist. It also has favorable ADME properties and good in vivo efficacy. | |||
T63167 | Antitrypanosomal agent 7 | ||
The Antitrypanosomal agent 7 (compound 18c) is a potent anti-trypanosome agent and shows good ADME properties. The Antitrypanosomal agent 7 was more than two-fold more active against T. brucei (IC50: 0.71 μM) than Nifurt... | |||
T60761 | PF-06305591 dihydrate | ||
PF-06305591 dihydrate is a potent and highly selective voltage gated sodium channel NaV1.8 blocker (IC 50 = 15 nM) with an excellent preclinical in vitro ADME and safety profile [1]. | |||
T81881 | MAGL-IN-10 | MAGL | |
MAGL-IN-10, a reversible monoacylglycerol lipase (MAGL) inhibitor, exhibits favorable ADME properties and low in vivo toxicity. It is applicable in the study of cancer, neurological disorders, and inflammatory pathologie... | |||
T70005 | LY3325656 | ||
LY3325656 is a GPR142 agonist suitable for clinical testing in human. LY3325656 demonstrated anti-diabetic benefits in pre-clinical studies and ADME/PK properties suitable for human dosing. LY3325656 is the first GPR1... | |||
T79316 | Antitrypanosomal agent 15 | Proteasome | |
Antitrypanosomal Agent 15 (Compound 26) is an orally active, brain-penetrant, selective inhibitor of the Trypanosoma cruzi proteasome, exhibiting a pIC50 of 7.4 for T. cruzi and <4 for the human proteasome. It possesses ... | |||
T62710 | Antitrypanosomal agent 6 | ||
Antitrypanosomal agent 6 (compound 18a) is a potent antitrypanosomal agent showing good ADME properties. Antitrypanosomal agent 6 is more than twice as active as Nifurtimox against Trypanosoma brucei (T. brucei) with an ... | |||
T79447 | IRAK4-IN-25 | IRAK | |
IRAK4-IN-25 (compound 38), a potent oral IRAK4 inhibitor (IC50 = 7.3 nM) with low clearance (Cl = 12 mL/min/kg), effectively suppresses pro-inflammatory cytokine production and demonstrates favorable in vitro safety and ... | |||
T71069 | GSK1842799 HCl | ||
GSK1842799 is a selective S1P1 receptor agonist for multiple sclerosis. Upon phosphorylation, GSK1842799 showed subnanomole S1P1 agonist activity with >1000× selectivity over S1P3. GSK1842799 demonstrated good oral bioa... | |||
T77254 | Maltodextrin, dextrose equivalent 16.5-19.5 | ||
Maltodextrin (dextrose equivalent 16.5-19.5) serves as an excipient in pharmaceutical applications. Excipients, also known as pharmaceutical auxiliaries, are chemical substances utilized in drug formulation alongside act... | |||
T72999 | PF-06455943 | ||
PF-06455943, a leucine rich repeat kinase 2 (LRRK2) inhibitor, exhibits an inhibition concentration (IC50) value of 3 nM and also functions as a PET radioligand. It is utilized in the research of ADME/neuro PK characteri... | |||
T16490 | PF-06380101 | Auristatin-0101,Aur0101 | Others |
PF-06380101 is an auristatin microtubule inhibitor and is a cytotoxic Dolastatin 10 analogue. When compared to other synthetic auristatin analogues that are used in the preparation of ADCs, PF-06380101 displays excellent... |